The NDTV report states that this compound is used in medieval and eastern Europe. It has not received a license in the rest of the world. Study says that if this less expensive compound is used in poor countries, then there may be a major change in global health.
The study published in journal addiction is based on the result of about 6,000 patients. Researchers conducted 8 tests comparing Systecin with Plessibo. Researchers came to the conclusion that siteicine increases the chances of shutting down from siteicine compared to the placebo.
Researchers also noticed that siteicine could be more effective than nicotine replacement therapy. Researchers stated that their study provides evidence that siteicin is an effective and cheap help preventing smoking. It can be very useful in reducing smoking in poor countries.
Systecin was first synthesized in 1964 as a tabex in Bulgaria and was later used to Eastern Europe.